Large-vessel vasculitis possibly induced by BRAF and MEK inhibitors for BRAF V600E positive lung adenocarcinoma
Article in BMJ Case Reports (May 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma
Article in Science Translational Medicine (October 2023)
Non-small-cell lung cancer: how to manage BRAF-mutated disease
Article in Drugs in Context (May 2023)